申请人:AbbVie Inc.
公开号:US10266532B2
公开(公告)日:2019-04-23
The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.
本发明提供了三环杂环化合物、药学上可接受的盐、原药、生物活性代谢物、立体异构体和异构体,其中的变量在本文中定义。本发明的化合物可用于治疗免疫学和肿瘤学疾病。